PMID- 24752656 OWN - NLM STAT- MEDLINE DCOM- 20151012 LR - 20211021 IS - 1432-2072 (Electronic) IS - 0033-3158 (Linking) VI - 231 IP - 21 DP - 2014 Oct TI - The self-administration of rapidly delivered cocaine promotes increased motivation to take the drug: contributions of prior levels of operant responding and cocaine intake. PG - 4241-52 LID - 10.1007/s00213-014-3576-4 [doi] AB - RATIONALE: Rapid drug delivery to the brain might increase the risk for developing addiction. In rats, increasing the speed of intravenous cocaine delivery (5 vs. 90 s) increases drug intake and the subsequent motivation to self-administer cocaine. Increased motivation for cocaine could result not only from more extensive prior drug intake and operant responding for drug, but also from neuroplasticity evoked by rapid drug uptake. OBJECTIVE: We determined the contributions of prior drug intake and operant responding to the increased motivation for cocaine evoked by rapid delivery. We also investigated the effects of cocaine delivery speed on corticostriatal expression of brain-derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrkB) mRNA. METHODS: Rats self-administered cocaine (0.25 mg/kg/infusion) delivered over 5 or 90 s during short-access (1 h/session; ShA) or long-access (6 h; LgA) sessions. Motivation for cocaine was then assessed by measuring responding under a progressive ratio schedule of reinforcement. Next, BDNF and TrkB mRNA levels were measured in 5- and 90-s rats. RESULTS: Five-second ShA and 5-s-LgA rats were more motivated for cocaine than their 90-s counterparts. This effect was dissociable from previous levels of drug intake or of operant responding for cocaine. In parallel, only rats self-administering rapid cocaine injections had altered BDNF and TrkB mRNA levels in corticostriatal regions. CONCLUSIONS: Rapid drug delivery augments the motivation for cocaine independently of effects on the levels of drug intake or operant responding for drug. We suggest that rapid delivery might increase the motivation for drug by promoting neuroplasticity within reward pathways. This neuroplasticity could involve increased regulation of BDNF/TrkB. FAU - Bouayad-Gervais, Karim AU - Bouayad-Gervais K AD - Department of Pharmacology, Faculty of Medicine, Universite de Montreal, C.P. 6128, Succursale Centre-Ville, Montreal, QC, H3C 3J7, Canada. FAU - Minogianis, Ellie-Anna AU - Minogianis EA FAU - Levesque, Daniel AU - Levesque D FAU - Samaha, Anne-Noel AU - Samaha AN LA - eng GR - 97841/Canadian Institutes of Health Research/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140422 PL - Germany TA - Psychopharmacology (Berl) JT - Psychopharmacology JID - 7608025 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Dopamine Uptake Inhibitors) RN - EC 2.7.10.1 (Receptor, trkB) RN - I5Y540LHVR (Cocaine) SB - IM MH - Animals MH - Behavior, Addictive/*metabolism MH - Brain-Derived Neurotrophic Factor/genetics/metabolism MH - Cerebral Cortex/drug effects/*metabolism MH - Cocaine/*administration & dosage MH - Conditioning, Operant/*drug effects MH - Corpus Striatum/drug effects/*metabolism MH - Dopamine Uptake Inhibitors/*administration & dosage MH - Dose-Response Relationship, Drug MH - Male MH - Motivation/*drug effects MH - Rats MH - Rats, Wistar MH - Receptor, trkB/genetics/metabolism MH - Reward MH - Self Administration EDAT- 2014/04/23 06:00 MHDA- 2015/10/13 06:00 CRDT- 2014/04/23 06:00 PHST- 2013/10/11 00:00 [received] PHST- 2014/04/02 00:00 [accepted] PHST- 2014/04/23 06:00 [entrez] PHST- 2014/04/23 06:00 [pubmed] PHST- 2015/10/13 06:00 [medline] AID - 10.1007/s00213-014-3576-4 [doi] PST - ppublish SO - Psychopharmacology (Berl). 2014 Oct;231(21):4241-52. doi: 10.1007/s00213-014-3576-4. Epub 2014 Apr 22.